Multisystem inflammatory syndrome in children related to COVID-19: a systematic review

被引:287
作者
Hoste, Levi [1 ,2 ]
Van Paemel, Ruben [3 ,4 ,5 ]
Haerynck, Filomeen [1 ,2 ]
机构
[1] Ghent Univ Hosp, Dept Pediat Pulmonol Infect Dis & Immunol, Ghent, Belgium
[2] Ghent Univ Hosp, Primary Immunodeficiency Res Lab, Ctr Primary Immunodeficiency Ghent, Jeffrey Modell Diag & Res Ctr, Ghent, Belgium
[3] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium
[4] Canc Res Inst Ghent CRIG, Ghent, Belgium
[5] Ghent Univ Hosp, Dept Pediat Hematol Oncol & Stem Cell Transplanta, Ghent, Belgium
关键词
PIMS-TS; MIS-C; COVID-19; SARS-CoV-2; MIMICKING KAWASAKI-DISEASE; SARS-COV-2; PIMS-TS; MIS-C; INVOLVEMENT; SHOCK; INFECTION; DIAGNOSIS;
D O I
10.1007/s00431-021-03993-5
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
An association between a novel pediatric hyperinflammatory condition and SARS-CoV-2 was recently published and termed pediatric inflammatory multisystem syndrome, temporally associated with SARS-CoV-2 (PIMS-TS) or multisystem inflammatory syndrome (in children) (MIS(-C)). We performed a systematic review and describe the epidemiological, clinical, and prognostic characteristics of 953 PIMS-TS/MIS(-C) cases in 68 records. Additionally, we studied the sensitivity of different case definitions that are currently applied. PIMS-TS/MIS(-C) presents at a median age of 8 years. Epidemiological enrichment for males (58.9%) and ethnic minorities (37.0% Black) is present. Apart from obesity (25.3%), comorbidities are rare. PIMS-TS/MIS(-C) is characterized by fever (99.4%), gastrointestinal (85.6%) and cardiocirculatory manifestations (79.3%), and increased inflammatory biomarkers. Nevertheless, 50.3% present respiratory symptoms as well. Over half of patients (56.3%) present with shock. The majority of the patients (73.3%) need intensive care treatment, including extracorporal membrane oxygenation (ECMO) in 3.8%. Despite severe disease, mortality is rather low (1.9%). Of the currently used case definitions, the WHO definition is preferred, as it is more precise, while encompassing most cases. Conclusion: PIMS-TS/MIS(-C) is a severe, heterogeneous disease with epidemiological enrichment for males, adolescents, and racial and ethnic minorities. However, mortality rate is low and short-term outcome favorable. Long-term follow-up of chronic complications and additional clinical research to elucidate the underlying pathogenesis is crucial. What is Known: A novel pediatric inflammatory syndrome with multisystem involvement has been described in association with SARS-CoV-2. To date, the scattered reporting of cases and use of different case definitions provides insufficient insight in the full clinical spectrum, epidemiological and immunological features, and prognosis. What is New: This systematic review illustrates the heterogeneous spectrum of PIMS-TS/MIS(-C) and its epidemiological enrichment for males, adolescents, and racial and ethnic minorities. Despite its severe presentation, overall short-term outcome is good. The WHO MIS definition is preferred, as it is more precise, while encompassing most cases.
引用
收藏
页码:2019 / 2034
页数:16
相关论文
共 102 条
[1]   Neurologic and Radiographic Findings Associated With COVID-19 Infection in Children [J].
Abdel-Mannan, Omar ;
Eyre, Michael ;
Lobel, Ulrike ;
Bamford, Alasdair ;
Eltze, Christin ;
Hameed, Biju ;
Hemingway, Cheryl ;
Hacohen, Yael .
JAMA NEUROLOGY, 2020, 77 (11) :1440-1445
[2]   Novel Coronavirus Mimicking Kawasaki Disease in an Infant [J].
Acharyya, Bhaswati C. ;
Acharyya, Saumyabrata ;
Das, Dhritabrata .
INDIAN PEDIATRICS, 2020, 57 (08) :753-754
[3]  
Al-Aamri M.A., 2020, medRxiv, DOI [10.1101/2020.07.08.20137497, DOI 10.1101/2020.07.08.20137497]
[4]  
[Anonymous], 2020, CDC MULTISYSTEM INFL
[5]  
[Anonymous], 2020, NOV COR CHIN
[6]   Hyperinflammatory shock related toCOVID-19 in a patient presenting with multisystem inflammatory syndrome in children: First case from Iran [J].
Bahrami, Ahmad ;
Vafapour, Maryam ;
Moazzami, Bobak ;
Rezaei, Nima .
JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2021, 57 (06) :922-925
[7]   Hyper-inflammatory Syndrome in a Child With COVID-19 Treated Successfully With Intravenous Immunoglobulin and Tocilizumab [J].
S. Balasubramanian ;
T. M. Nagendran ;
B. Ramachandran ;
A. V. Ramanan .
Indian Pediatrics, 2020, 57 (7) :681-683
[8]   Special dermatological presentation of paediatric multisystem inflammatory syndrome related to COVID-19: erythema multiforme [J].
Bapst, Thomas ;
Romano, Fabrizio ;
Mueller, Marie ;
Rohr, Marie .
BMJ CASE REPORTS, 2020, 13 (06)
[9]   Acute Heart Failure in Multisystem Inflammatory Syndrome in Children in the Context of Global SARS-CoV-2 Pandemic [J].
Belhadjer, Zahra ;
Meot, Mathilde ;
Bajolle, Fanny ;
Khraiche, Diala ;
Legendre, Antoine ;
Abakka, Samya ;
Auriau, Johanne ;
Grimaud, Marion ;
Oualha, Mehdi ;
Beghetti, Maurice ;
Wacker, Julie ;
Ovaert, Caroline ;
Hascoet, Sebastien ;
Selegny, Maelle ;
Malekzadeh-Milani, Sophie ;
Maltret, Alice ;
Bosser, Gilles ;
Giroux, Nathan ;
Bonnemains, Laurent ;
Bordet, Jeanne ;
Di Filippo, Sylvie ;
Mauran, Pierre ;
Falcon-Eicher, Sylvie ;
Thambo, Jean-Benoit ;
Lefort, Bruno ;
Moceri, Pamela ;
Houyel, Lucile ;
Renolleau, Sylvain ;
Bonnet, Damien .
CIRCULATION, 2020, 142 (05) :429-436
[10]   Cardiac involvement in a pediatric patient with COVID-19: Looking beyond the nonspecific global cardiac injury [J].
Bhansali, Suneet ;
Minocha, Prashant ;
Phoon, Colin ;
Henry, Gillian ;
Chakravarti, Sujata ;
Ramirez, Michelle ;
Bhatla, Puneet .
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2020, 37 (09) :1488-1491